Enliven Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for ELVN stock has a target of 34, which predicts an increase of 92.96% from the current stock price of 17.62.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$34	$34	$34	$34
Change	+92.96%	+92.96%	+92.96%	+92.96%

Analyst Ratings

According to 1 stock analyst, the rating for ELVN is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	1	1	1	1
Buy	1	1	1	0
Hold	0	0	0	0
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Salim Syed Mizuho	Mizuho	Strong Buy Initiates $34	Strong Buy	Initiates	$34	+92.96%	Apr 9, 2024
Eun Yang Jefferies	Jefferies	Strong Buy Initiates $27	Strong Buy	Initiates	$27	+53.23%	Mar 29, 2023
Phil Nadeau TD Cowen	TD Cowen	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Mar 3, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-2.47

from -2.01

EPS Next Year

-3.08

from -2.47

Year	2019	2020	2021	2022	2023	2024	2025	2026
Revenue	-	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-133.60	-14.12	-9.48	-12.05	-2.01	-2.47	-3.08	-3.15
EPS Growth	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2024	2025	2026
High	-2.25	-2.52	-3.00
Avg	-2.47	-3.08	-3.15
Low	-2.58	-3.75	-3.26

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.